Patents by Inventor Robert James Houlden

Robert James Houlden has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210290496
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Application
    Filed: June 4, 2021
    Publication date: September 23, 2021
    Inventors: Michael JOHNSTON, Robert James HOULDEN
  • Patent number: 11071694
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Grant
    Filed: May 31, 2018
    Date of Patent: July 27, 2021
    Assignee: Rose U, LLC
    Inventors: Michael Johnston, Robert James Houlden
  • Publication number: 20180311116
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Application
    Filed: May 31, 2018
    Publication date: November 1, 2018
    Inventors: Michael JOHNSTON, Robert James HOULDEN
  • Patent number: 10052267
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Grant
    Filed: July 27, 2017
    Date of Patent: August 21, 2018
    Assignee: ROSE U, LLC
    Inventors: Michael Johnston, Robert James Houlden
  • Publication number: 20180008517
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Application
    Filed: July 27, 2017
    Publication date: January 11, 2018
    Inventors: Michael JOHNSTON, Robert James HOULDEN
  • Patent number: 9744105
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: August 29, 2017
    Assignee: ROSE U, LLC
    Inventors: Michael Johnston, Robert James Houlden
  • Patent number: 9211237
    Abstract: The present invention provides a foam composition comprising an active agent. In particular, the foam composition produces a water resistant, preferably very water resistant, film upon application.
    Type: Grant
    Filed: September 17, 2013
    Date of Patent: December 15, 2015
    Assignee: STIEFEL RESEARCH AUSTRALIA PTY LTD
    Inventors: Joan Kathleen Huggins, Robert James Houlden
  • Publication number: 20140170080
    Abstract: The present invention relates to topical aerosol compositions comprising L-ascorbic acid. The compositions comprise (a) L-ascorbic acid, or a pharmaceutically acceptable salt or ester thereof, (b) water, (c) lower alcohol and (d) an aerosol propellant. In particular embodiments of the invention, the formulations are actuated as an aerosol spray or aerosol foam. The formulations are suitable for minimizing aging of the skin.
    Type: Application
    Filed: August 10, 2012
    Publication date: June 19, 2014
    Applicant: STIEFEL RESEARCH AUSTRALIA PTY LTD.
    Inventors: Lilian Fuchshuber, Robert James Houlden
  • Publication number: 20140151255
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Application
    Filed: November 19, 2013
    Publication date: June 5, 2014
    Applicant: ROSE U
    Inventors: Michael JOHNSTON, Robert James HOULDEN
  • Publication number: 20140017176
    Abstract: The present invention provides a foam composition comprising an active agent. In particular, the foam composition produces a water resistant, preferably very water resistant, film upon application.
    Type: Application
    Filed: September 17, 2013
    Publication date: January 16, 2014
    Applicant: STIEFEL RESEARCH AUSTRALIA PTY LTD
    Inventors: Joan Kathleen HUGGINS, Robert James HOULDEN
  • Patent number: 8629128
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: January 14, 2014
    Assignee: Stiefel West Coast, LLC
    Inventors: Richard Buchta, Robert James Houlden, Maria Graziella Larm, Leon Loupenok, Rose Ye
  • Patent number: 8618160
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: December 31, 2013
    Assignee: Rose U
    Inventors: Michael Johnston, Robert James Houlden
  • Patent number: 8562959
    Abstract: The present invention provides a foam composition comprising an active agent. In particular, the foam composition produces a water resistant, preferably very water resistant, film upon application.
    Type: Grant
    Filed: July 22, 2005
    Date of Patent: October 22, 2013
    Assignee: Stiefel Research Australia Pty Ltd
    Inventors: Joan Kathleen Huggins, Robert James Houlden
  • Publication number: 20130101525
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Application
    Filed: September 20, 2012
    Publication date: April 25, 2013
    Applicant: STIEFEL RESEARCH AUSTRALIA PTY LTD
    Inventors: Richard BUCHTA, Robert James HOULDEN, Maria Graziella LARM, Leon LOUPENOK, Rose YE
  • Patent number: 8298515
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: October 30, 2012
    Assignee: Stiefel Research Australia Pty Ltd.
    Inventors: Richard Buchta, Robert James Houlden, Maria Graziella Larm, Leon Loupenok, Rose Ye
  • Patent number: 8263580
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: September 11, 2012
    Assignee: Stiefel Research Australia Pty Ltd
    Inventors: Richard Buchta, Robert James Houlden, Rose Ye, Maria Graziella Larm, Leon Loupenok
  • Publication number: 20100276329
    Abstract: Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.
    Type: Application
    Filed: October 17, 2008
    Publication date: November 4, 2010
    Inventors: Michael Johnston, Robert James Houlden